Cisatracurium vs Succinylcholine 2026

Two paralytics, two completely different jobs. Succinylcholine is the fast, short intubating drug; cisatracurium is the clean, organ-independent infusion for sustained paralysis. Confusing them is dangerous.

One-line distinction: Succinylcholine is a depolarizing agent used for rapid-sequence intubation — seconds to onset, minutes to gone. Cisatracurium is a non-depolarizing agent used as a continuous infusion for prolonged paralysis (ARDS, refractory vent dyssynchrony) — and it is uniquely safe in organ failure.

Head-to-head

Why cisatracurium is the ICU infusion of choice

	Succinylcholine	Cisatracurium
Class	Depolarizing NMBA	Non-depolarizing (benzylisoquinolinium)
Onset	~30–60 seconds	~2–3 minutes
Duration	~5–10 minutes	~30–45 min (bolus); titratable infusion
Primary use	Rapid-sequence intubation	Sustained paralysis (ARDS, dyssynchrony, ICP)
Elimination	Plasma cholinesterase	Hofmann elimination (organ-independent)
Reversal	None — wait it out	Neostigmine/sugammadex not for cisatra; wears off

Cisatracurium is broken down by Hofmann elimination — a spontaneous chemical degradation driven by normal body temperature and pH that does not depend on the liver or kidneys. That makes it predictable in the exact patients the ICU is full of: hepatic failure, renal failure, and multi-organ dysfunction. Its metabolism does not pile up when organs fail, so recovery time stays consistent. That reliability is why it is the default paralytic infusion for ARDS lung-protective ventilation and severe vent dyssynchrony.

Succinylcholine's danger list

Hyperkalemia can be fatal. Succinylcholine transiently raises serum potassium, and in susceptible patients it can cause a lethal spike. Avoid it in burns (after ~24–48 h), crush/denervation injuries, prolonged immobility, severe hyperkalemia, and certain neuromuscular diseases — up-regulated receptors can dump enough potassium to arrest the heart. It is also a trigger for malignant hyperthermia; know where the dantrolene is. And it causes fasciculations and a rise in intracranial, intraocular, and intragastric pressure.

The nursing safety points that apply to both

Sedation and analgesia first, always. A paralyzed patient who is not deeply sedated is awake, aware, and unable to move or signal — a catastrophic experience. Paralytics have zero sedative or analgesic effect. Confirm adequate sedation and analgesia are running before and throughout any paralysis, and never let a paralytic infusion outlast the sedation.

Monitor depth with train-of-four. For cisatracurium infusions, titrate to a train-of-four of 1–2 twitches, not to zero — complete blockade risks prolonged weakness. Protect the eyes and skin (lubricate and tape lids; reposition to prevent pressure injury — the patient cannot shift themselves). Secure the airway and alarms — a paralyzed patient has no respiratory drive and no ability to protect the tube.

Bottom line for the ICU nurse: Reach for succinylcholine only in the intubation moment, and screen hard for hyperkalemia risk and MH history first. Reach for cisatracurium when you need clean, organ-independent, titratable paralysis over hours — and never, for either drug, without deep sedation and analgesia layered underneath.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify doses independently.

Get The ICU Notebook Newsletter

Clinical tools and career insights for ICU nurses. One email per week, no fluff.

Yes, send it free

No spam. Unsubscribe any time.

Head-to-head

Why cisatracurium is the ICU infusion of choice

Succinylcholine's danger list

The nursing safety points that apply to both

Related Articles